NCT07867782

Brief Summary

This single-center, single-blind, randomized controlled trial evaluates whether the use of a conversational large language model (LLM)-based AI agent, used by caregivers during the waiting period before physician consultation in a pediatric emergency department (ED), affects the caregiver-perceived effectiveness of clinical information delivery compared with standard care. The AI agent collects and summarizes the child's symptoms via voice before the consultation and does not participate in any diagnostic, prescribing, or treatment decisions. A total of 34 caregivers were enrolled at Samsung Medical Center.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 18, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 12, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 12, 2026

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 27, 2026

Completed
12 days until next milestone

First Posted

Study publicly available on registry

October 9, 2026

Completed
Last Updated

October 9, 2026

Status Verified

October 1, 2026

Enrollment Period

2 months

First QC Date

September 27, 2026

Last Update Submit

October 6, 2026

Conditions

Keywords

pediatric emergency departmentAI agent

Outcome Measures

Primary Outcomes (1)

  • Caregiver-perceived effectiveness of clinical information delivery (PART 2-1)

    Caregiver-perceived effectiveness of clinical information delivery, measured with an investigator-developed exploratory instrument (PART 2-1). Five items on a 5-point Likert scale (total score range 5 to 25); higher scores indicate better perceived information delivery.

    Once, after completion of the index emergency department visit (assessed within approximately 1 hour after ED discharge)

Secondary Outcomes (2)

  • ED communication and service experience (PART 1 and PART 2-2 to 2-9)

    Within 1 hour after emergency department discharge

  • Emergency department length of stay

    From emergency department arrival to discharge, assessed up to 24 hours

Study Arms (2)

AI Agent (Intervention)

EXPERIMENTAL

Caregivers used the LLM-based AI agent on a study tablet for approximately 5 to 10 minutes during the pre-consultation waiting period, before the physician consultation.

Other: AI Agent (conversational LLM pre-consultation history-taking tool)

Standard Care (Control)

NO INTERVENTION

Caregivers received usual pediatric emergency department care without using the AI agent.

Interventions

A conversational large language model (LLM)-based AI agent used by caregivers on a study tablet before the physician consultation to collect and summarize the child's symptoms. It functions as a pre-consultation history-taking support tool and does not make diagnostic, prescribing, or treatment decisions.

AI Agent (Intervention)

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Caregiver aged 19 years or older of a child younger than 18 years presenting to the Samsung Medical Center pediatric emergency department
  • Able to self-report and complete the questionnaire
  • Provides written informed consent

You may not qualify if:

  • Critical or emergent status (e.g., Korean Triage and Acuity Scale level 1)
  • Caregiver unable to self-report
  • Visual or hearing impairment precluding participation
  • Refusal to participate
  • Duplicate participation
  • Otherwise unsuitable for the study objectives per investigator judgment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Samsung Medical Center

Seoul, 06351, South Korea

Location

MeSH Terms

Conditions

Communication

Condition Hierarchy (Ancestors)

Behavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 27, 2026

First Posted

October 9, 2026

Study Start

June 18, 2026

Primary Completion

August 12, 2026

Study Completion

August 12, 2026

Last Updated

October 9, 2026

Record last verified: 2026-10

Locations